Search Results - anahid+jewett

5 Results Sort By:
Combination of Supercharged NK with Supercharged Gamma Delta T Cells and Supercharged CD8+ T Cells and Super Charged iNKT Cells Should Eliminate Both (UCLA Case No. 2022-322)
SUMMARY: Researchers at UCLA’s School of Dentistry have developed methods and protocols for culturing and priming various immune cells into a “supercharged” phenotype. The studied cell types include NK and iNKT cells, gamma delta T cells, and CD8+ T cells. When deployed in combination, these supercharged cells were found to eliminate...
Published: 7/17/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Oncology, Therapeutics > Oncology > Oncology Immunotherapy
2022-014 Prevention of Bone Loss With Probiotic Bacteria AJ2 and/or Super-Charged NK Cells in Cancer and Other Diseases
SUMMARY: UCLA researchers in the School of Dentistry have discovered novel therapeutic methods involving probiotic bacteria and super-charged natural killer cells that successfully prevent bone loss in pancreatic cancer, with huge therapeutic potential for other cancer types and diseases. BACKGROUND: Metabolic bone disorders are associated with several...
Published: 7/17/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Oncology, Therapeutics > Oncology > Oncology Immunotherapy, Therapeutics > Orthopaedics
Combining Autologous or Allogeneic Total Monocytes or CD16+ Monocytes to Protect and Increase the Expansion and Function of Stem Cells (UCLA Case No. 2021-182)
SUMMARY: UCLA researchers in the department of Dentistry have developed a novel approach to increase the successful transplantation and survival of stem cells into patients. BACKGROUND: The World Health Organization has recognized that transplantation of human cells saves and restores essential life functions to patients who are not presented with...
Published: 7/17/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics, Therapeutics > CNS and Neurology, Therapeutics > Immunology And Immunotherapy, Therapeutics > Stem Cells And Regenerative Medicine, Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells
2021-129 USE OF COX2 KNOCK OUT MONOCYTES AND OSTEOCLASTS TO ACTIVATE AND EXPAND NK CELLS
SUMMARY: UCLA Researchers in the Department of Dentistry have developed a procedure to increase immune response in cancer patients. BACKGROUND: Natural killer (NK) cells are a type of cytotoxic lymphocyte critical to the innate immune system. NK cells provide rapid responses to viral infection and are also crucial to inhibiting tumor formation. They...
Published: 7/17/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Immunology And Immunotherapy, Therapeutics > Oncology, Therapeutics > Oncology > Oncology Immunotherapy
2006-585 DETOXIFIED AND OSTEOCONDUCTIVE BONE CEMENT
INTRO SENTENCE: UCLA researchers have developed a novel bone cement material for the treatment of osteoporotic fractures and degenerative joint disorders.BACKGROUND:Bone cement is a critical component of various types of orthopedic surgery that is used as spacers and for fixation of implants. Bone cement can be loaded with antibiotics to help with the...
Published: 7/17/2025   |   Inventor(s): Takahiro Ogawa, Anahid Jewett
Keywords(s): Medical Devices and Materials, Musculoskeletal Disease
Category(s): Therapeutics > Musculoskeletal Disease